Literature DB >> 19574635

Structure of the lamin A/C R482W mutant responsible for dominant familial partial lipodystrophy (FPLD).

Eugenia Magracheva1, Serguei Kozlov, Colin L Stewart, Alexander Wlodawer, Alexander Zdanov.   

Abstract

Proteins of the A-type lamin family, which consists of two members, lamin A and lamin C, are the major components of a thin proteinaceous filamentous meshwork, the lamina, that underlies the inner nuclear membrane. A-type lamins have recently become the focus of extensive functional studies as a consequence of the linking of at least eight congenital diseases to mutations in the lamin A/C gene (LMNA). This spectrum of pathologies, which mostly manifest themselves as dominant traits, includes muscle dystrophies, dilated cardiomyopathies, the premature aging syndrome Hutchinson-Guilford progeria and familial partial lipodystrophy (FPLD). The crystal structure of the lamin A/C mutant R482W, a variant that causes FPLD, has been determined at 1.5 A resolution. A completely novel aggregation state of the C-terminal globular domain and the position of the mutated amino-acid residue suggest means by which the mutation may affect lamin A/C-protein and protein-DNA interactions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19574635      PMCID: PMC2705630          DOI: 10.1107/S1744309109020302

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  13 in total

1.  Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy.

Authors:  H Cao; R A Hegele
Journal:  Hum Mol Genet       Date:  2000-01-01       Impact factor: 6.150

2.  The carboxyl-terminal region common to lamins A and C contains a DNA binding domain.

Authors:  Vérène Stierlé; Joël Couprie; Cecilia Ostlund; Isabelle Krimm; Sophie Zinn-Justin; Paul Hossenlopp; Howard J Worman; Jean-Claude Courvalin; Isabelle Duband-Goulet
Journal:  Biochemistry       Date:  2003-05-06       Impact factor: 3.162

3.  LMNA, encoding lamin A/C, is mutated in partial lipodystrophy.

Authors:  S Shackleton; D J Lloyd; S N Jackson; R Evans; M F Niermeijer; B M Singh; H Schmidt; G Brabant; S Kumar; P N Durrington; S Gregory; S O'Rahilly; R C Trembath
Journal:  Nat Genet       Date:  2000-02       Impact factor: 38.330

4.  The Ig-like structure of the C-terminal domain of lamin A/C, mutated in muscular dystrophies, cardiomyopathy, and partial lipodystrophy.

Authors:  Isabelle Krimm; Cecilia Ostlund; Bernard Gilquin; Joël Couprie; Paul Hossenlopp; Jean-Paul Mornon; Gisèle Bonne; Jean-Claude Courvalin; Howard J Worman; Sophie Zinn-Justin
Journal:  Structure       Date:  2002-06       Impact factor: 5.006

Review 5.  The laminopathies: nuclear structure meets disease.

Authors:  Leslie Mounkes; Serguei Kozlov; Brian Burke; Colin L Stewart
Journal:  Curr Opin Genet Dev       Date:  2003-06       Impact factor: 5.578

6.  Crystallography & NMR system: A new software suite for macromolecular structure determination.

Authors:  A T Brünger; P D Adams; G M Clore; W L DeLano; P Gros; R W Grosse-Kunstleve; J S Jiang; J Kuszewski; M Nilges; N S Pannu; R J Read; L M Rice; T Simonson; G L Warren
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1998-09-01

7.  Structure of the globular tail of nuclear lamin.

Authors:  Sirano Dhe-Paganon; Eric D Werner; Young-In Chi; Steven E Shoelson
Journal:  J Biol Chem       Date:  2002-03-18       Impact factor: 5.157

8.  Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C.

Authors:  R A Speckman; A Garg; F Du; L Bennett; R Veile; E Arioglu; S I Taylor; M Lovett; A M Bowcock
Journal:  Am J Hum Genet       Date:  2000-04       Impact factor: 11.025

9.  Control of tetrapyrrole biosynthesis by alternate quaternary forms of porphobilinogen synthase.

Authors:  Sabine Breinig; Jukka Kervinen; Linda Stith; Andrew S Wasson; Robert Fairman; Alexander Wlodawer; Alexander Zdanov; Eileen K Jaffe
Journal:  Nat Struct Biol       Date:  2003-08-03

10.  Nuclear envelope disorganization in fibroblasts from lipodystrophic patients with heterozygous R482Q/W mutations in the lamin A/C gene.

Authors:  C Vigouroux; M Auclair; E Dubosclard; M Pouchelet; J Capeau; J C Courvalin; B Buendia
Journal:  J Cell Sci       Date:  2001-12       Impact factor: 5.285

View more
  6 in total

Review 1.  Broken nuclei--lamins, nuclear mechanics, and disease.

Authors:  Patricia M Davidson; Jan Lammerding
Journal:  Trends Cell Biol       Date:  2013-12-02       Impact factor: 20.808

2.  Myopathic lamin mutations cause reductive stress and activate the nrf2/keap-1 pathway.

Authors:  George Dialynas; Om K Shrestha; Jessica M Ponce; Monika Zwerger; Dylan A Thiemann; Grant H Young; Steven A Moore; Liping Yu; Jan Lammerding; Lori L Wallrath
Journal:  PLoS Genet       Date:  2015-05-21       Impact factor: 5.917

Review 3.  Laminopathies: the molecular background of the disease and the prospects for its treatment.

Authors:  Magdalena Zaremba-Czogalla; Magda Dubińska-Magiera; Ryszard Rzepecki
Journal:  Cell Mol Biol Lett       Date:  2010-12-27       Impact factor: 5.787

4.  Structural analysis of the ternary complex between lamin A/C, BAF and emerin identifies an interface disrupted in autosomal recessive progeroid diseases.

Authors:  Camille Samson; Ambre Petitalot; Florian Celli; Isaline Herrada; Virginie Ropars; Marie-Hélène Le Du; Naïma Nhiri; Eric Jacquet; Ana-Andrea Arteni; Brigitte Buendia; Sophie Zinn-Justin
Journal:  Nucleic Acids Res       Date:  2018-11-02       Impact factor: 16.971

5.  Monoclonal antibodies specific for disease-associated point-mutants: lamin A/C R453W and R482W.

Authors:  Marko Roblek; Stefan Schüchner; Veronika Huber; Katrin Ollram; Sylvia Vlcek-Vesely; Roland Foisner; Manfed Wehnert; Egon Ogris
Journal:  PLoS One       Date:  2010-05-13       Impact factor: 3.240

Review 6.  A Perspective on the Experimental Techniques for Studying Lamins.

Authors:  Ilaria Pecorari; Daniele Borin; Orfeo Sbaizero
Journal:  Cells       Date:  2017-10-10       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.